Juan Londono, MD
Cardiovascular Disease · Miami Beach, FLNPI 1871595645
Payments from drug & device makers
Across 592 payments — averaging $3866.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Therapeutics, Inc.$912K
- Astrazeneca UK Limited$486K
- Amgen$335K
- AstraZeneca$324K
- Novartis$229K
- Medtronic$941
- plus $2K from 18 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Therapeutics, Inc. | 391 | $912,295 |
| Astrazeneca UK Limited | 2 | $485,811 |
| Amgen | 34 | $335,388 |
| AstraZeneca | 28 | $323,608 |
| Novartis | 22 | $229,221 |
| Medtronic(2 entities) | 13 | $941 |
| E.r. Squibb & Sons, L.L.C. | 20 | $386 |
| Johnson & Johnson | 18 | $318 |
| Pfizer | 11 | $195 |
| Amarin Pharma, Inc. | 10 | $184 |
| Boehringer Ingelheim | 6 | $133 |
| Sanofi-aventis U.S. LLC | 6 | $112 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $103 |
| Bayer | 4 | $73 |
| Baxter Healthcare | 2 | $68 |
| Actelion Pharmaceuticals US, Inc. | 4 | $61 |
| Abbott | 3 | $60 |
| Impulse Dynamics (USA) Inc. | 2 | $50 |
| Arbor Pharmaceuticals, Inc. | 3 | $46 |
| Novo Nordisk | 2 | $35 |
| Currax Pharmaceuticals LLC | 2 | $28 |
| Philips North America LLC | 1 | $20 |
| Merck | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
How this compares
$2,289,169 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Miami Beach
- Michael KorenGainesville$31M
- Seth BaumBoca Raton$11.1M
- Alexis GutierrezHialeah$8M
- Eric SpivackAventura$7.1M
- William OneillNaples$4.6M
- Rafik AbadierInverness$4.4M
- Alvaro MurciaPembroke Pines$4M
- David HotchkissPort Charlotte$4M
- Ferris GeorgeSt Augustine$3.8M
- Duccio BaldariWellington$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.